The antidepressant-like effect of formononetin on chronic corticosterone-treated mice. 2022

Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
Henan Key Laboratory for Modern Research on Zhongjing's Herbal Formulae, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, PR China; College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, PR China. Electronic address: zhangcj933@163.com.

Previous studies reported the neuroprotective effects of formononetin (FMN), however, whether it has antidepressant-like effects have not been reported. To evaluate the antidepressant-like effects of FMN, a mice model of depression was established by chronic corticosterone (CORT) injection. The serum corticosterone levels and hippocampal protein expression were detected by ELISA and Western blot. Nissl staining was used to observe the damage of hippocampal neurons and immunofluorescence was used to observe the neurogenesis in the hippocampus. Our results showed that FMN significantly increased the sucrose preference and shorten the immobility time in the forced swimming test in CORT-treated mice. Moreover, FMN reduced the serum corticosterone levels, upregulated the protein expression levels of the glucocorticoid receptor (GR), and brain-derived neurotrophic factor (BDNF) in the hippocampus, protected against the CORT-induced neuronal impairment, and promoted the neurogenesis in the hippocampus. Taken together, the present study was the first to demonstrate the antidepressant-like effects of FMN in the CORT-induced mice model of depression, which may contribute to the discovery of a new candidate for treating depression.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D019208 Brain-Derived Neurotrophic Factor A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. (From Kendrew, The Encyclopedia of Molecular Biology, 1994) BDNF,Brain Derived Neurotrophic Factor,Factor, Brain-Derived Neurotrophic,Neurotrophic Factor, Brain-Derived

Related Publications

Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
September 2010, Journal of pineal research,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
May 2019, Brain research,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
January 2024, Journal of molecular neuroscience : MN,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
September 2022, Biochemical and biophysical research communications,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
April 2006, Behavioral neuroscience,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
August 2010, Neuroscience letters,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
May 2008, Pharmacology, biochemistry, and behavior,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
February 2017, Neurochemical research,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
March 2015, Genes, brain, and behavior,
Changjing Zhang, and Leilei Zhu, and Shuaifei Lu, and Mengyuan Li, and Ming Bai, and Yucheng Li, and Erping Xu
January 2012, Journal of pharmacological sciences,
Copied contents to your clipboard!